Yakov Baranes bought $24k of QXL
Co-CEO at QUANTUM X LABS INC.. 5,000 shares at an average of $4.88, traded Sep 15, 2026, filed Sep 17, 2026.
Score components
- +25RoleCEO
- 0Trade size$24k at market
- 0Relative to holdingsHoldings up 1.4%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-043041, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | POpen-market purchase Common Stock, par value $0.0001 per share | +5,000 | $4.88 | $24k | 358,177 | 26 d ago |
Related signals
Other insiders at QUANTUM X LABS INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 61Notable | QXLbuy QUANTUM X LABS INC. | Eliyahu Yoresh director | $260k 260,000 shares | +3203% | |
| 33Weak | QXLbuy QUANTUM X LABS INC. | Eliyahu Yoresh director | $25k 5,144 shares | +173% | |
| 29Weak | QUANTUM X LABS INC. | Yoram Baumann director | $9,444 9,444 shares | +33% | |
| 39Weak | QUANTUM X LABS INC. | Amihay Hadad Chief Executive Officer | $2,518 2,518 shares | +33% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.